[R01] Structural definition of CD4-induced HIV-1 Env conformational changes required for infection
Ente: National Institute of Allergy and Infectious Diseases
Scadenza: 2030-07-31
Importo max: 791.914 EUR
Paese: US
Descrizione
The HIV-1 envelope glycoprotein (Env), a homotrimer of gp120-gp41 heterodimers, mediates viral entry into
host cells. The gp120 subunit engages host receptors, while the gp41 subunit contains a fusion peptide (FP)
that is inserted into the host membrane to induce host and virus membrane fusion. Prior to its binding to host
receptors, the HIV-1 Env is characterized by a closed configuration with gp120 protomers packed against
each other and the gp41 subunit, while the highly conserved and immunodominant coreceptor-binding region
at the Env trimer apex remains occluded by packing of the first and second (V1V2) as well as the third (V3)
variable loops. At the trimer base, FP comprises a hydrophobic stretch of about 20 amino acids at the gp41
N terminus that is accessible for antibody binding in the closed configuration of Env. FP is a site of
vulnerability to broadly neutralizing antibodies (bnAbs) and thus of vaccine focus. Until recently, two distinct
structural configurations of the FP were defined in the literature, one that is antibody accessible in the pre-
fusion closed Env and a second that is sequestered within a gp41-gp120 pocket in a partially or fully open
CD4-induced Env. We recently described a functional intermediate state in atomic level details where the FP
remains accessible to antibody binding despite substantial receptor binding mediated Env opening. In the
study, Aim 1 will focus on the early stages of Env opening, including the role that the unique FP configuration
in HIV-1 plays in the metastability of the pre-fusion, pre-receptor, closed Env and how this impacts the Env
conformational landscape. Aim 2 will focus on detailed characterization of a newly defined functional
intermediate state. Aim 3 will focus on later stages of Env opening where the FP gets buried within a
hydrophobic core and is no longer available for antibody binding. These studies will advance our
understanding of the HIV-1 entry mechanism and inform structure-based immunogen and drug design. The
scientific premise of this grant is that the FP is a critical component of the HIV-1 entry machinery that
determines virus attachment. Understanding the mechanistic basis of the movement of the FP during the
entry process is thus critical to our understanding of HIV-1 biology. A mechanistic understanding of
subsequent conformational changes and the intermediate states uncovered in the process will facilitate the
development of intervention strategies that include immunogen design for HIV-1 vaccine efforts and drug
design for novel cure AIDS strategies to eliminate the latent pool of HIV-1-infected CD4 T cells. The
innovation in this grant derives from our discovery of a novel receptor-bound Env intermediate that shows
substantial opening yet can bind a FP-directed antibody. The proposed studies will improve our
understanding of HIV-1 entry and will inform vaccine and therapeutics development.
Istituzione: DUKE UNIVERSITY
PI: Priyamvada Acharya
Progetto: 5R01AI145687-07
Settori: National Institute of Allergy and Infectious Diseases
Vai al bando originale
Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.